{"id":180336,"date":"2025-12-12T06:24:13","date_gmt":"2025-12-12T06:24:13","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/180336\/"},"modified":"2025-12-12T06:24:13","modified_gmt":"2025-12-12T06:24:13","slug":"medlines-blockbuster-ipo-and-its-billionaire-founding-family","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/180336\/","title":{"rendered":"Medline\u2019s Blockbuster IPO\u2013And Its Billionaire Founding Family"},"content":{"rendered":"

In this week\u2019s edition of InnovationRx, Medline\u2019s blockbuster IPO, Fred Moll\u2019s surgical robotics investments, Forbes\u2019 inaugural top hospitals list, and more. To get it in your inbox, subscribe here<\/a>.<\/p>\n

Charlie Mills, Medline\u2019s former CEO and a key member of its founding family<\/p>\n

AFP via Getty Images<\/p>\n

Medical supplies giant Medline\u2019s IPO is set to be this winter\u2019s blockbuster\u2013worth up to $55 billion. Documents for it also reveal for the first time the remaining stake of the Mills family, who founded the company in 1910 and ran it for generations. The family sold a majority stake to private equity in 2021 in a deal that valued the company at $30 billion.<\/p>\n

A new securities filing<\/a> shows that the Mills family\u2019s stake is worth $6 billion to $7 billion,<\/a> by Forbes estimates based on the disclosed shareholdings of Mozart HoldCo and an expected share price of $26-to-$30 per share, raising $5 billion total. Combined with estimated pretax proceeds of more than $22 billion from the earlier deal,<\/a> that would give the Mills family\u2013including Charlie Mills, the company\u2019s former CEO; Andy Mills, his cousin and former president; and Jim Abrams, Andy\u2019s brother-in-law and the former chief operating officer\u2013a combined net worth of at least $20 billion by Forbes estimates<\/a>.<\/p>\n

Though Medline\u2019s supplies, which include everything from baby blankets to bandages, are everywhere, the Mills family was largely unknown until Forbes profiled them in 2020<\/a> in the early days of the COVID-19 pandemic. At the time, its distribution of medical supplies to nursing homes, pharmacies and 45% of hospital systems nationwide was a critical part of the country\u2019s coronavirus response.<\/p>\n

Under private-equity ownership, and with a non-family CEO in Jim Boyle for the past two years, the company has been growing and profitable: Sales reached $25.5 billion in 2024, while profits rebounded to $1.2 billion.<\/p>\n

This Robotic Surgery Legend Is Pouring $100 Million Into Next-Gen Medical Startups<\/p>\n

Dr. Fred Moll<\/p>\n

Courtesy of Fred Moll<\/p>\n

Dr. Fred Moll left the practice of medicine more than four decades ago. But he\u2019s responsible for some 3 million surgeries a year, done by robots that he helped invent as the cofounder of Intuitive Surgical, the leader in robotic surgeries with more than 10,000 machines deployed and $8.4 billion in 2024 revenue.<\/p>\n

Now, three decades after its founding and nearly 25 years since he departed Intuitive to start more companies, Moll has plowed around $100 million of his own funds into the next generation of surgical robotics startups. Colonoscopies. Cataract surgeries. Heart-valve replacements. One day, he\u2019s betting these and a slew of other medical procedures will be performed by robots, improved over time by AI that analyzes what\u2019s worked and what hasn\u2019t in similar situations in the past. The goal is to bring the best medical care to everyone, whether they\u2019re in New York or Nagpur.<\/p>\n

\u201cI\u2019ve spent my career watching other people do surgery. The difference between a good surgeon and an average surgeon is massive,\u201d Moll, 73, told Forbes. \u201cMy ambition is that the robot can do procedures that people struggle with. Its impact is to raise the level of capability of average surgeons to very good surgeons in procedures that not everyone is good at.\u201d<\/p>\n

Read the whole story<\/a>. <\/p>\n

The Forbes Top Hospitals List<\/p>\n

Introducing Forbes\u2019 newest list: Forbes Top Hospitals 2026<\/a>. This unbiased, data-driven rating system cuts through the confusion to identify general acute care hospitals across the country offering high-quality healthcare services. These inaugural ratings are meant to serve the best interests of patients while offering hospital leaders a unique vantage point with which to evaluate their facility\u2019s performance in comparison with their peers.<\/p>\n

To produce this list, Forbes partnered with Inovalon<\/a>, a healthcare data and analytics firm, and collaborated with nationally recognized measurement experts, physicians, statisticians, health policy researchers and patient advocates.<\/p>\n

Read more about the list here<\/a>. To learn more about the methodology, click here<\/a>. For answers to frequently asked questions about the ratings, click here<\/a>.<\/p>\n

Deal of the Week<\/p>\n

Freenome, which is developing blood tests for early cancer detection, is going public in a SPAC deal<\/a>. The Brisbane, California-based firm said that it would merge with Perceptive Capital Solutions Corp., in a $330 million deal that includes a $240 million investment from healthcare investors<\/a> led by Perceptive Advisors and RA Capital. Freenome, which has deals with Roche and Exact Sciences, is one of a number of companies working on blood-based tests for cancer. Last month, in a sign of just how much promise is riding on them, Abbott announced that it would acquire Exact in a $21 billion deal.<\/a> Freenome CEO Aaron Elliot has said that the company expects to launch multiple tests in 2026.<\/p>\n

What We\u2019re Reading<\/p>\n

The CDC\u2019s vaccine advisory panel voted last week to stop recommending<\/a> hepatitis B vaccines to newborns\u2013but health insurers plan to continue covering them<\/a>. <\/p>\n

While that hepatitis B vote may not have much impact now, the committee is laying the groundwork to undermine future vaccine development, argues<\/a> Forbes contributor Joshua Cohen. <\/p>\n

Humana and Mark Cuban\u2019s Cost Plus Drugs<\/a> are working on a partnership to lower prescription prices.<\/p>\n

People who have health insurance under the Affordable Care Act<\/a> will pay more\u2013and get plans that have higher deductibles and cover less. <\/p>\n

A rural North Carolina hospital that was slated to open in 2025 is still a dirt field<\/a> with its future plans stuck in bureaucracy.<\/p>\n

Indian billionaire Kiran Mazumdar-Shaw\u2019s Biocon is buying out<\/a> its privately-held subsidiary Biocon Biologics in a deal that values the biologics unit at $5.5 billion.<\/p>\n

U.K. biotech Relation will work with Novartis to find allergic disease drug targets<\/a> in a deal worth up to $1.7 billion. <\/p>\n

Eli Lilly plans to be \u201caggressive\u201d<\/a> in spending the money it\u2019s bringing in from GLP-1 drugs Zepbound and Mounjaro.<\/p>\n

People vaccinated for COVID-19 had a 74% lower risk of death from severe disease than those who were unvaccinated, a 4-year follow-up study found<\/a>. <\/p>\n

Mark Cuban On Drug Costs<\/p>\n

At last week\u2019s Forbes Healthcare Summit, billionaire Mark Cuban and Humana CEO Jim Rechtin discussed the challenges of making drugs more affordable and how they would work together to do so. Watch the session below. <\/p>\n

More From ForbesForbesHow The Leaders On The Forbes\u2019 Power Women List Prevailed In The Face Of A Rough 2025By Maggie McGrath<\/a>ForbesNetflix\u2019s Queen Of ScreensBy Maneet Ahuja<\/a>ForbesFormula 1\u2019s Highest-Paid Drivers 2025By Brett Knight<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"In this week\u2019s edition of InnovationRx, Medline\u2019s blockbuster IPO, Fred Moll\u2019s surgical robotics investments, Forbes\u2019 inaugural top hospitals…\n","protected":false},"author":2,"featured_media":180337,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[105237,105236,100730,105235,163,521,20473,85,46,105233,105234,54766,105232,9804],"class_list":{"0":"post-180336","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-billionaire-families","9":"tag-blockbuster-ipo","10":"tag-fred-moll","11":"tag-freenome","12":"tag-health","13":"tag-healthcare","14":"tag-healthtech","15":"tag-il","16":"tag-israel","17":"tag-medline","18":"tag-mills-family","19":"tag-surgical-robots","20":"tag-top-hospitals","21":"tag-vaccines"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/180336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=180336"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/180336\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/180337"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=180336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=180336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=180336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}